|
Your link to the latest news on research, treatment, prevention and education from the state's only
National Cancer Institute-designated Comprehensive Cancer Center
|
|
|
Toppmeyer Named CINJ Chief Medical Officer
Deborah Toppmeyer, MD, an associate professor of medicine at UMDNJ-Robert Wood Johnson Medical School, has been appointed chief medical officer of The Cancer Institute of New Jersey (CINJ). In this role, she will be responsible for compliance with all clinical medical policies, regulations and clinical performance standards. She will also have oversight and responsibility for all of CINJ's clinical objectives and serve as CINJ's ultimate authority on medical issues. Dr. Toppmeyer joined CINJ in 1995 from the Dana Farber Cancer Institute at Harvard Medical School and is a renowned researcher and clinician in the area of breast cancer and the genetics of breast cancer. In addition to her new role as chief medical officer, Toppmeyer will remain the director of CINJ's Stacy Goldstein Breast Cancer Center and the LIFE Center, as well as the chief of solid tumor oncology.
|
|
Free Prostate Cancer Screenings Offered in September
In recognition of National Prostate Cancer Awareness Month, The Cancer Institute of New Jersey and its flagship hospital Robert Wood Johnson University Hospital once again are teaming up to provide free prostate cancer screenings September 19, 20 and 21. An appointment is required and can be made by calling 1-888-637-9584. One in six men will be diagnosed with prostate cancer and it is the most frequently diagnosed cancer in men other than skin cancer. That is why CINJ and RWJUH join forces each year to educate men and their families about this disease through the annual prostate cancer screening event.Read more
|
|
Menthol Cigarettes May Make it Tougher to Quit Smoking for
Certain Populations
Could a mint-flavored additive to cigarettes have a negative impact on smoking cessation efforts? New research from investigators at The Cancer Institute of New Jersey and UMDNJ-School of Public Health shines a light on this topic. It finds that menthol cigarettes are associated with decreased quitting in the United States, and that this effect is more pronounced for blacks and Puerto Ricans. The findings, which appeared in the August 15th online edition of American Journal of Preventive Medicine, are ideally timed as the FDA's Center for Tobacco Products is currently considering banning menthol cigarettes after its own Tobacco Product Scientific Advisory Committee (TPSAC) concluded that "removal of menthol cigarettes from the marketplace would benefit public health in the United States."Read more
|
|
Small Molecules Found to Play Complex Roles in Cancer Metastasis
While they may be small in size, a family of tiny molecules called microRNAs could potentially play a large role in the process of cancer metastasis, or the spread of cancer from one area of the body to another. A team of researchers led by CINJ member Yibin Kang, PhD, and his Princeton University laboratory, along with European colleagues, have revealed that miR-200s play a paradoxical role in the development of metastatic cancer. On the one hand, these microRNAs slow down the initial escape of cells from the primary breast tumor into blood circulation, impeding the spread of cancer at that point in the process. However when tumor cells do escape and then seek to colonize new organs such as the lungs, the same miR-200s facilitate that process. The study is described in the August 7th online edition of Nature Medicine.Read more
|
|
Healthy Male Volunteers Needed for Selenium Study
Are you willing to step up to the plate? Researchers at The Cancer Institute of New Jersey are studying the effects of the mineral selenium in reducing one's risk for prostate cancer. At focus are selenium yeast or selenomethionine and whether they have a role in lowering prostate-specific antigen (PSA) levels and preventing other markers related to the development of prostate cancer in healthy men of different ages. Participants will be asked to take over-the-counter selenium supplements or a placebo for twelve months.Read more
|
|
|
|
|
|
|
|
